NEWSROOM
Latest healthcare articles and information
National pharmacare plan a political pill or cure-all?
Macleans by Anne Kingston
Jun 13, 2019
Anne Kingston: These are still just recommendations. But now that the spotlight has turned on Medicare’s incomplete mandate, it will be difficult for politicians to step away.
Towards Implementation of National Pharmacare Discussion Paper
A Message from the Minister of Health and the Minister of Finance
Canadians are proud of our publicly funded health care system, which is based on need and not ability to pay. However, prescription drugs are not covered in a consistent way across the country, and too many Canadians cannot afford the medicines they need.
Liberal MP battling cancer calls on colleagues to act ‘honourably’
Globe and Mail, Ottawa, Laura Stone, Published June 12, 2017
A Liberal MP who has been battling cancer for more than two years delivered an emotional plea for civility in the House of Commons on Monday as he acknowledged his health is declining.
Patient advocacy experts gather to start a conversation on cancer immunotherapy in Canada
Inaugural patient summit brings together experts across oncology to collaborate on patient access to innovative cancer treatments and foster collaboration amongst patient groups and the medical community to improve patient outcomes.
New Cancer Immunotherapy Indication for Canadian Patients with Untreated Metastatic Melanoma
KIRKLAND, QC May 31, 2016 /CNW Telbec/ – Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today that KEYTRUDA® (pembrolizumab) received approval for the treatment of patients with unresectable or metastatic melanoma who have not received prior treatment with ipilimumab. KEYTRUDA is now the first and only anti-PD1 agent approved for first-line treatment regardless of BRAF mutation status.